Madona Azar is an Endocrinology/Metabolic physician affiliated with UMass Memorial Health Care. OpenAlex indexes 33 publications with 403 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Lake Ave N
Worcester, MA 016550002
Telephone
508-334-3206Provider last certified this registry record 22 Sept 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
89.1%GLP-1 receptor agonist29.7%Ozempic40%Trulicity31%Mounjaro28%Rybelsus2%Part D<11 patientsInsulin Analog20.6%Lantus Solostar30%Basaglar Kwikpen U-10016%Tresiba Flextouch U-10010%Humalog Kwikpen U-1008%Novolog Flexpen7%Tresiba Flextouch U-2006%Insulin Lispro Kwikpen U-1005%Lantus4%Fiasp Flextouch4%Humalog3%Admelog Solostar3%Toujeo Max Solostar3%Fiasp2%Part D<11 patients+ 5 more classes in this area
Cardiovascular
7%Statin3.2%Atorvastatin Calcium76%Rosuvastatin Calcium24%Part D<11 patientsACE inhibitor1.5%Lisinopril100%Part D≥17 patients+ 4 more classes in this area
Nervous system
1.9%SNRI1.1%Duloxetine Hcl100%Part D<11 patientsGabapentinoids0.8%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Adherence to Screening Recommendations for Diabetic Nephropathy in Lebanese Patients With Diabetes
Panorama of emergency medicine.
2025 - IMPACT OF ONCE-WEEKLY SUBCUTANEOUS SEMAGLUTIDE 2.4 MG ON METABOLIC SYNDROME IN THE 2-YEAR, RANDOMIZED CONTROLLED STEP 5 TRIAL
Canadian Journal of Cardiology
2023 - IMPACT OF ONCE-WEEKLY SUBCUTANEOUS SEMAGLUTIDE 2.4 MG ON METABOLIC SYNDROME IN THE 2-YEAR, RANDOMIZED CONTROLLED STEP 5 TRIAL
Canadian Journal of Diabetes
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gerard Aurigemma, MD
UMass Memorial Health Care
Richard Irwin, MD
UMass Memorial Health Care
Craig Lilly, MD
UMass Memorial Health Care
David Keefe, MD
UMass Memorial Health Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”